. Purpose. To assess urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor binding protein 7 ([TIMP-2]⋅[IGFBP7]), urinary neutrophil gelatinase-associated lipocalin (NGAL), and urinary cystatin-C as acute kidney injury predictors (AKI) exploring the association of nonrenal factors with elevated biomarker levels. Methods. We studied 94 patients with urine collected within 48 hours of ICU admission and no AKI at sampling. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria. , NGAL, and cystatin-C should be used cautiously as AKI predictors in general ICU patients since urine levels of these biomarkers are affected by factors other than AKI and their performance can be poor
The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is incr...
Acute Kidney Injury (AKI) is a prevalent systemic disorder that has an extremely high rate of mortal...
Acute kidney injury (AKI) is a serious complication, commonly occurring in the critically ill popula...
Purpose. To assess urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor b...
Purpose. To assess urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor b...
Background: Acute kidney injury (AKI) diagnosis is based on a rise in serum creatinine and/or fall i...
Background: Acute kidney injury (AKI) is routinely diagnosed by creatinine-based guidelines, which i...
Background and objectives: Several novel urinary biomarkers have shown promise in the early detectio...
To analyse the usefulness of the composite index of the tissue inhibitor of metalloproteinases-2 (TI...
Background Post-resuscitation care after out-of-hospital cardiac arrest (OHCA) is ch...
Introduction: Early recognition of patients developing acute kidney injury (AKI) is of considerable ...
Acute kidney injury is common in critically ill patients and portends a significant impact on mortal...
Abstract Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function...
Objectives:Decreased urine output and/or increased serum creatinine may herald the development of ac...
Background/Aims Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth fac...
The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is incr...
Acute Kidney Injury (AKI) is a prevalent systemic disorder that has an extremely high rate of mortal...
Acute kidney injury (AKI) is a serious complication, commonly occurring in the critically ill popula...
Purpose. To assess urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor b...
Purpose. To assess urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor b...
Background: Acute kidney injury (AKI) diagnosis is based on a rise in serum creatinine and/or fall i...
Background: Acute kidney injury (AKI) is routinely diagnosed by creatinine-based guidelines, which i...
Background and objectives: Several novel urinary biomarkers have shown promise in the early detectio...
To analyse the usefulness of the composite index of the tissue inhibitor of metalloproteinases-2 (TI...
Background Post-resuscitation care after out-of-hospital cardiac arrest (OHCA) is ch...
Introduction: Early recognition of patients developing acute kidney injury (AKI) is of considerable ...
Acute kidney injury is common in critically ill patients and portends a significant impact on mortal...
Abstract Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function...
Objectives:Decreased urine output and/or increased serum creatinine may herald the development of ac...
Background/Aims Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth fac...
The incidence of acute kidney injury (AKI) formerly referred to as acute renal failure (ARF) is incr...
Acute Kidney Injury (AKI) is a prevalent systemic disorder that has an extremely high rate of mortal...
Acute kidney injury (AKI) is a serious complication, commonly occurring in the critically ill popula...